Filing Details

Accession Number:
0001209191-22-056423
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-10 17:10:36
Reporting Period:
2022-11-08
Accepted Time:
2022-11-10 17:10:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496323 Igm Biosciences Inc. IGMS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211701 Kathleen M Behrens C/O Igm Biosciences, Inc.
325 E. Middlefield Road
Mountain View CA 94043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-08 60,000 $17.14 218,200 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,394 Direct
Common Stock 29,807 Indirect See footnote
Common Stock 29,806 Indirect See footnote
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $16.94 to $17.25. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate purchase price.
  2. The shares are held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
  3. The shares are held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
  4. The shares are held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.